US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Cochlear (PK) (CHEOF) 銘柄情報

Cochlear (PK) (CHEOF)

81.42

0.00

(0.00%)

終了 7月5日 5:00AM

Cochlear (PK) (CHEOF) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

81.42

( - )

買値

80.21

売値

87.55

出来高

-

0.00 日の範囲 0.00

64.3944 52 週間の範囲 207.71

時価総額

前日終値

81.42

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 700,659

発行済株式数

65,398,681

配当利回り

4.3 (4.30%)

PER

22.48

1 株当たり利益 (EPS)

5.27

歳入

2.34B

純利益

345.3M

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal ... Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories. The company was founded in 1981 and is headquartered in Sydney, Australia. 詳細を表示

セクター

Healthcare

業界

Medical Equipment & Supplies

ウェブサイト

www.cochlear.com

本社

Sydney, Australia

設立

1981

Cochlear (PK) is listed in the Healthcare sector of the その他OTC with ticker CHEOF. The last closing price for Cochlear (PK) was US$81.42. Over the last year, Cochlear (PK) shares have traded in a share price range of US$ 64.3944 to US$ 207.71.

Cochlear (PK) currently has 65,398,681 shares in issue. The market capitalisation of Cochlear (PK) is US$5.32 billion. Cochlear (PK) has a price to earnings ratio (PE ratio) of 22.48.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	1.94	2.44086562657	79.48	82.305	79.48	10715	82.12536816	CS
4	13.375	19.6561099273	68.045	82.305	68.045	2981	81.24260369	CS
12	-43.2496	-34.6913762457	124.6696	129.23	64.3944	2807	75.60772749	CS
26	-87.65	-51.8424321287	169.07	197.11	64.3944	1853	80.24058255	CS
52	-116.7	-58.9036947305	198.12	207.71	64.3944	998	83.44395633	CS
156	-68.81	-45.8031019104	150.23	237.38	64.3944	469	110.11623457	CS
260	-102.58	-55.75	184	237.38	64.3944	357	118.79668266	CS

CHEOF - Frequently Asked Questions (FAQ)

What is the current Cochlear (PK) share price?

The current share price of Cochlear (PK) is US$ 81.42

How many Cochlear (PK) shares are in issue?

Cochlear (PK) has 65,398,681 shares in issue

What is the market cap of Cochlear (PK)?

The market capitalisation of Cochlear (PK) is USD 5.32B

What is the 1 year trading range for Cochlear (PK) share price?

Cochlear (PK) has traded in the range of US$ 64.3944 to US$ 207.71 during the past year

What is the PE ratio of Cochlear (PK)?

The price to earnings ratio of Cochlear (PK) is 22.48

What is the cash to sales ratio of Cochlear (PK)?

The cash to sales ratio of Cochlear (PK) is 3.31

What is the registered address of Cochlear (PK)?

The registered address for Cochlear (PK) is 1 University Avenue, Sydney, New South Wales, 2109

What is the Cochlear (PK) website address?

The website address for Cochlear (PK) is www.cochlear.com

Which industry sector does Cochlear (PK) operate in?

Cochlear (PK) operates in the Medical Equipment & Supplies sector

DocLee

Flipper, the evidence is very compelling..... except for those who are working against NWBO for the likes of whom whom my old Granny used to say, "There's none so blind as them as won't see".

Best wishes.

DMC8

https://www.linkedin.com/posts/amarin-corporation_fourthofjuly-hearthealth-diseaseprevention-activity-7479267579304267776-Uhab?utm_source=share&utm_medium=member_ios&rcm=ACoAAAappXEBEo5xWglK2bmEx478x0aaRWW4o7I

Genz2

https://trustedcomputinggroup.org/enhancing-data-security-and-residency-through-trusted-confidential-computing/

The TCC model, backed by the security standards developed by the TCG, provides a scalable and verifiable solution to enforce data residency while preventing potentially crit

DMC8

Rethinking triglycerides in the management of ASCVD
Published: 03 July 2026
https://academic.oup.com/eurjpc/advance-article/doi/10.1093/eurjpc/zwag341/8724415

Soog

along4zride

along4zride 1時間前

Did you see on the credits for the Giant 250 DC fireworks show “brought to you by (FNMA)”. On behalf of the entire country I would like to thank the unselfish shareholders for their generous donation while they watched profits go up in smoke.

spdpro

spdpro 1時間前

nice flag > I have one that was flown over the Arizona Memorial
I received it when I retired from military in Hawaii > pretty sacred

DangFool

DangFool 1時間前

I thought their failure to make annual filings was was put it on the Pink Sheets in the first place.

Anyway, it seems they're willing to leave the Pink Sheets a no-man's land of massive fraud.

Wanted to point out that I was wrong before when I said Foley'd been acquitte

shajandr

shajandr 2時間前

My genetic progenitors dint arrive in the USA until more than a hunnert years after 1776. I am only a fourth and fifth generation Merrikun. Hell, I'm still trying to learn the langwitch.

https://investorshub.advfn.com/uimage/uploads/2026/7/5/aktqwPolish-Immigrants.png
https://i

lakers17

lakers17 2時間前

Yamamoto 7 scoreless as Dodgers beat San Diego again and win 3-0 to go 59-31 and go up 15 on the Padres. Sheehan pitches on Sunday maybe the weakest Dodger starter. Dodgers keep winning with Glasgow and Snell out.

muee88

muee88 2時間前

True. But logic says that the probability is slim that this data hasn’t already been submitted to MHRA.

satter

satter 2時間前

Is that possible? Asking that of someone who writes to the SEC authority a complaint with blame with containing no evidence of it.

gfp927z

gfp927z 2時間前

More on the new US national Stablecoin, as well as the Fed's plan to gradually 'inflate away' the US national debt -

(see 10:00 - 15:00) -

https://youtu.be/Y4FSMYSt2zQ

---

gfp927z

gfp927z 2時間前

US Stablecoin consortium -

A huge development last week for the coming US national Stablecoin system. 140 of the biggest players in finance are forming a consortium to run and own the new US digital dollar / stablecoin system they call 'Open US' (links below). The stablecoin is lik

gfp927z

gfp927z 2時間前

More on the new US national Stablecoin, as well as the Fed's plan to gradually 'inflate away' the US national debt -

(see 10:00 - 15:00) -

https://youtu.be/Y4FSMYSt2zQ

---

gfp927z

gfp927z 2時間前

More on the new US national Stablecoin, as well as the Fed's plan to gradually 'inflate away' the US national debt -

(see 10:00 - 15:00) -

https://youtu.be/Y4FSMYSt2zQ

---

gfp927z

gfp927z 2時間前

US Stablecoin consortium -

A huge development last week for the coming US national Stablecoin system. 140 of the biggest players in finance are forming a consortium to run and own the new US digital dollar / stablecoin system they call 'Open US' (links below). The stablecoin is lik

gfp927z

gfp927z 2時間前

Bigworld, It looks like a huge development last week for the coming US national Stablecoin system. 140 of the biggest players in finance are forming a consortium to run and own the new US digital dollar / stablecoin system they call 'Open US' (links below). The stablecoin is like a CBDC (digital

Twiggs333

Twiggs333 2時間前

GW Pharmaceuticals / Epidiolex is the pathway precedent people should be studying with respect to psychedelic biotech.

Jazz Pharmaceuticals acquired GW Pharmaceuticals for approximately $7.2 billion.

Why does that matter for psychedelic biotech?

Because G

Twiggs333

Twiggs333 2時間前

GW Pharmaceuticals / Epidiolex is the pathway precedent people should be studying with respect to psychedelic biotech.

Jazz Pharmaceuticals acquired GW Pharmaceuticals for approximately $7.2 billion.

Why does that matter for psychedelic biotech?

Because G

Twiggs333

Twiggs333 2時間前

GW Pharmaceuticals / Epidiolex is the pathway precedent people should be studying with respect to psychedelic biotech.

Jazz Pharmaceuticals acquired GW Pharmaceuticals for approximately $7.2 billion.

Why does that matter for psychedelic biotech?

Because G

Twiggs333

Twiggs333 2時間前

GW Pharmaceuticals / Epidiolex is the pathway precedent people should be studying with respect to psychedelic biotech.

Jazz Pharmaceuticals acquired GW Pharmaceuticals for approximately $7.2 billion.

Why does that matter for psychedelic biotech?

Because G

OMOLIVES

OMOLIVES 3時間前

Happy Fourth of July to all!...and a big thank you to the French. Vive la France!:

https://x.com/Phoenix2A_1980s/status/2073453266428387385

4u2nv2

4u2nv2 3時間前

Every filing from the time Paul and Ben took over said there were 3 preferred shareholders. The third one was never named. Now, it's interesting to question how Newby got controlling interest when we do not know all of the facts concerning what Ben really wanted to accomplish with taking on the comm

Nyesa Valores Corporacion

Amundi US Treasury Bond ...

International bond 0.5% ...

ASN Biodiversiteitsfonds...

Novo Integrated Sciences

Artec Global Media (EM)

PGIM S&P 500 Buffer 20 E...

ASN Duurzaam Aandelenfonds

Bretagne Region maturity...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。